-Yasufumi Kaneda Researcher Activity Profile

Research Author Detailed Information 

Yasufumi Kaneda Publication Rate By Year

Yasufumi Kaneda has published 20 paper(s) in 2007, 7 paper(s) in 2008, for a total of 27 research publications in total.

Yasufumi Y Kaneda Author Information

LAST NAME: kaneda

FIRST NAME: yasufumi

INITIALS: Y

AFFILIATION:

Papers

Yasufumi Kaneda's Publication Record

1. Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Year Published: 2007
Division of Gene Therapy Science, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
2. Needleless intranasal administration of HVJ-E containing allergen attenuates experimental allergic rhinitis. Year Published: 2007
Department of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
3. Involvement of gamma-secretase in postnatal angiogenesis. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
4. Involvement of gamma-secretase in postnatal angiogenesis. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
5. Development of tissue-targeting hemagglutinating virus of Japan envelope vector for successful delivery of therapeutic gene to mouse skin. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
6. Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation. Year Published: 2007
Division of Gene Therapy Science, Osaka University Medical School, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan, kaneday@gts.med.osaka-u.ac.jp.
7. Development of a transferrin receptor-targeting HVJ-E vector. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
8. Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor kappaB and ets in a rabbit model. Year Published: 2007
Department of Clinical Gene Therapy, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan.
9. Anticancer Immunotherapy using Inactivated Sendai Virus Particles. Year Published: 2007
10. [Anticancer immunotherapy using inactivated Sendai virus particles] Year Published: 2007
kurooka@gts.med.osaka-u.ac.jp
11. Development of tissue-targeting hemagglutinating virus of Japan envelope vector for successful delivery of therapeutic gene to mouse skin. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
12. Development of a transferrin receptor-targeting HVJ-E vector. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
13. Functional modification of Sendai virus by siRNA. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
14. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Year Published: 2008
Division of Gene Therapy Science, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
15. Needleless intranasal administration of HVJ-E containing allergen attenuates experimental allergic rhinitis. Year Published: 2007
Department of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
16. Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor kappaB and ets in a rabbit model. Year Published: 2007
Department of Clinical Gene Therapy, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan.
17. Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosis. Year Published: 2008
Division of Clinical Gene Therapy, Osaka University Graduate School of Medical, 2-2 Yamada-oka, Suita 565-0871, Japan. morishit@cgt.med.osaka-u.ac.jp.
18. Current status of gene therapy in Asia. Year Published: 2008
1Department of Biological Sciences, Seoul National University, Seoul, Korea.
19. Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation. Year Published: 2007
Division of Gene Therapy Science, Osaka University Medical School, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
20. Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems. Year Published: 2008
Professor Osaka University Graduate School of Medicine, Division of Gene Therapy Science, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan +81 6 6879 3900 ; +81 6 6879 3909 ; kaneday@gts.med.osaka-u.ac.jp.
21. Involvement of gamma-secretase in postnatal angiogenesis. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
22. Rapid transport of plasmid DNA into the nucleolus via actin depolymerization using the HVJ envelope vector. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
23. [Anticancer immunotherapy using inactivated Sendai virus particles] Year Published: 2007
kurooka@gts.med.osaka-u.ac.jp
24. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Year Published: 2008
Division of Gene Therapy Science, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
25. Functional modification of Sendai virus by siRNA. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
26. Potential role of CYLD (Cylindromatosis) as a deubiquitinating enzyme in vascular cells. Year Published: 2008
Department of Geriatric Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
27. Cutaneous gene delivery. Year Published: 2008
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.